Ignite Creation Date:
2025-12-24 @ 12:15 PM
Ignite Modification Date:
2025-12-27 @ 10:46 PM
Study NCT ID:
NCT01030861
Status:
COMPLETED
Last Update Posted:
2020-08-05
First Post:
2009-12-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-11
First Submit QC Date:
None
Study First Post Date:
2009-12-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-02
Results First Submit QC Date:
None
Results First Post Date:
2020-08-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-21
Last Update Post Date:
2020-08-05
Last Update Post Date Type:
ACTUAL